Citius Pharmaceuticals, Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Citius Pharmaceuticals, Inc. stock issued during period, value, other for the quarter ending 2024-12-31 was $2.57M.
- Citius Pharmaceuticals, Inc. stock issued during period, value, other for the quarter ending 2024-06-30 was $13.72M.
- Citius Pharmaceuticals, Inc. stock issued during period, value, other for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- Citius Pharmaceuticals, Inc. stock issued during period, value, other for the quarter ending 2017-03-31 was $308.95K, a 91.30% decline year-over-year.
- Citius Pharmaceuticals, Inc. stock issued during period, value, other for fiscal 2025 was $4.73M, a 65.73% decline from fiscal 2024.
- Citius Pharmaceuticals, Inc. stock issued during period, value, other for fiscal 2024 was $13.80M.
- Citius Pharmaceuticals, Inc. stock issued during period, value, other for fiscal 2016 was $4.23M, a 470.69% increase from fiscal 2015.
- Citius Pharmaceuticals, Inc. stock issued during period, value, other for fiscal 2015 was $741.06K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2025-09-30 | $4.73M 10-K · filed 2025-12-23 | |
| 2024-12-31 | $2.57M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $13.80M 10-K · filed 2024-12-27 | |
| 2024-06-30 | $13.72M 10-Q · filed 2025-08-12 | |
| 2017-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-14 | $491.35K derived: sum of 4 quarters · filed 2017-08-14 |
| 2017-03-31 | $308.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-15 | $1.03M derived: sum of 4 quarters · filed 2017-05-15 |
| 2016-12-31 | $182.40K 10-Q · filed 2017-02-14 | $4.27M derived: sum of 4 quarters · filed 2017-02-14 |
| 2016-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-23 | $4.23M 10-K · filed 2016-12-23 |
| 2016-06-30 | $534.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-15 | $4.43M derived: sum of 4 quarters · filed 2016-12-23 |
| 2016-03-31 | $3.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-20 | $4.29M derived: sum of 4 quarters · filed 2016-12-23 |
| 2015-12-31 | $144.45K 10-Q · filed 2016-02-12 | |
| 2015-09-30 | $200.06K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-23 | $741.06K 10-K · filed 2016-12-23 |
| 2015-06-30 | $398.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |